This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jean Mixer Joins NxStage Board Of Directors

LAWRENCE, Mass., Nov. 9, 2012 /PRNewswire/ -- NxStage ® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the appointment of Jean Mixer to its Board of Directors.

(Logo:  http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Ms. Mixer is the Chief Executive Officer of mixerconsulting which focuses on helping organizations grow their business through strategic and governance work.  She was formerly a partner at The Boston Consulting Group (BCG), a global strategy consulting firm, where she worked for over a decade.  She has worked across the restructuring healthcare value chain including working with leading biopharmaceutical, medical device, pharmacy, insurance and integrated health care delivery networks.  Prior to joining BCG, Ms. Mixer was an officer at JP Morgan in New York.  She brings 25 years of public company experience.

Since 2006 Ms. Mixer has served as a Director on the Board of the Cambridge Trust Company, Chair of the Compensation Committee, and a member of the Executive Committee.  She is also the Chair of the HR board committee for the Boys and Girls Clubs of Boston.  Formerly, she served on the Business Round Table Committee on National Health Care Reform.

"We are delighted that Jean has joined the Board of Directors of NxStage Medical," said Jeffrey Burbank, Chief Executive Officer, NxStage Medical, Inc.  "Jean's experience in strategic development within the healthcare industry, coupled with her business acumen, will bring additional valuable perspective to our Board.  I look forward to her contributions as we advance NxStage's growth strategy."

"I am excited to join the Board of Directors of a health care company pioneering significant advancements in renal care," stated Ms. Mixer. "NxStage's innovative technologies have the potential to deliver life-changing outcomes for patients. NxStage's solutions enable patients to do their dialysis treatments more frequently in home, aligning well with the increasing focus of policymakers, payers and healthcare providers on superior outcomes and more patient-centered care in the home."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs